A new Canadian guideline on HIV prevention emphasizes the patient’s role in decisions related to pre-exposure prophylaxis (PrEP) and postexposure prophylaxis (PEP) prescriptions. It also highlighted ...
– New Data from PURPOSE Trials Further Demonstrate that Lenacapavir (Yeztugo ®) was Effective and Well Tolerated Across a Broad Range of Populations, Including Pregnant and Lactating Women, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results